Form 4: Neumora Therapeutics Director Transfers Shares to Family Trusts

Paul L. Berns, a director at Neumora Therapeutics, transferred shares of common stock to family trusts on December 27, 2024.

Summary

• On December 27, 2024, Paul L. Berns, a director of Neumora Therapeutics, Inc., transferred 133,097 shares of common stock to each of three family trusts: LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB.
• The transfers were made for no consideration.
• Members of Mr. Berns' immediate family are the sole beneficiaries of these trusts.
• Following the transactions, Mr. Berns directly owns 7,685,069 shares and indirectly owns 133,097 shares through each of the three trusts.

Sentiment

Score: 5

Explanation: This Form 4 filing is a neutral event, simply reflecting a transfer of shares for estate planning purposes. It doesn't inherently indicate positive or negative sentiment towards the company.

Industry Context

This is a routine disclosure of insider transactions and doesn't necessarily reflect a change in the company's outlook or performance.

Related Party Transactions

• The transfer of shares to family trusts constitutes a related party transaction.

Stakeholder Impact

• The transfer of shares has minimal impact on stakeholders as it is a personal transaction of a director and does not affect the company's operations or financial position.

Key Dates